Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 269

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 269
---
 if any, of the fair market value of the shares of common stock or cash received over any amount paid for the shares of common stock thereby, and ParentCo will generally be entitled to deduct such amount at such time.

A U.S. Participant who receives a restricted stock award generally recognizes ordinary compensation income equal to the excess, if any, of the fair market value of such common stock at the time the restriction lapses over any amount paid thereby for the common stock. Alternatively, the U.S. Participant may elect to be taxed on the fair market value of such shares of common stock at the time of this grant. ParentCo will generally be entitled to a deduction at the same time and in the same amount as the income is required to be included by the U.S. Participant.

A U.S. Participant who receives an unrestricted stock award generally recognizes ordinary compensation income equal to the excess, if any, of the fair market value of such common stock on the date of grant. Liminatus Pharma, Inc. will generally be entitled to a deduction for such amount.

Interests of Iris’s Directors and Officers in the Incentive Plan Proposal

When you consider the recommendation of the Iris Board in favor of approval of the Incentive Plan, you should keep in mind that certain members of the Iris Board and officers have interests in the Incentive Plan that are different from, or in addition to, your interests as a stockholder or warrant holder, including, among other things, the potential future issuance of awards to officers and directors of the Combined Company.

#### Required Vote for Approval
The approval of the Incentive Plan Proposal requires the affirmative vote of a majority of the votes cast by stockholders present in person or represented by proxy and entitled to vote thereon at the Special Meeting (which would include presence by virtual attendance at the Special Meeting). An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the Incentive Plan Proposal will be considered as non-discretionary) nor count as a vote cast in the Special Meeting.

Adoption of the Incentive Plan Proposal is conditioned on the approval of the Business Combination Proposal, the Election of Directors Proposal, and the Nasdaq Proposal at the Special Meeting.

The closing is conditioned on the approval of the Business Combination Proposal, the Election of Directors Proposal, the Incentive Plan Proposal and the Nasdaq Proposal at the Special Meeting.

####